A Phase II Study in Patients With Moderate to Severe Active Ulcerative Colitis.
- First Posted Date
- 2018-09-18
- Last Posted Date
- 2023-06-02
- Lead Sponsor
- Reistone Biopharma Company Limited
- Target Recruit Count
- 164
- Registration Number
- NCT03675477
- Locations
- 🇺🇸
Wellness Clinical Research, LLLC-Central Florida, Lake Wales, Florida, United States
🇺🇦Central City Clinical Hospital Dept of Theraphy No. 2 SHEI Ivano-Frankivsk NMU, Ivano-Frankivs'k, Ukraine
🇵🇱Nzoz Formed, Wadowice, Poland
© Copyright 2025. All Rights Reserved by MedPath